GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of the gastric emptying thing finally clicked for me and I want to write it down — 15 comments in the full submission. View in context.
-95
c/glp1science·submitted 3 months ago by u/formulary_fighter

the gastric emptying thing finally clicked for me and I want to write it down

Needs Sourcebranch of 6 comments

the gastric emptying thing finally clicked for me and I want to write it down. Change my mind, genuinely — I have no stake in being right about this. Tried to build a mental model from mechanism alone and produced a confident prediction that the trial data flatly contradicted. Spent an evening on the receptor…

Read the full submission and all 15 comments →

This branch

6 comments, started 3 months ago
u/saskia_lokken3 points·3 months ago

Yes. The discussion section is where the authors say what they actually think, and almost nobody here reads it.

replysharereportpermalink
u/ismael_eriksen4 points·3 months ago

Tolerance to the gastric effect develops with continued exposure while the appetite effect largely persists. That single fact explains most of the "it settles but it still works" pattern the side-effect board reports.

replysharereportpermalink
u/formulary_fighterOPappeals2 points·3 months ago

Is there any human data on that mechanism yet?

replysharereportpermalink
u/bastian_ekstrom1 point·3 months ago

glucagon agonism sounds paradoxical until you read the energy expenditure work

replysharereportpermalink
u/lurker_for_years2 points·3 months ago·edited

Are we talking about receptor affinity or clinical potency?

replysharereportpermalink
u/farid_kuipers1 point·3 months ago

That study was in a rodent model. Worth stating, since the thread has been reading it as human data.

replysharereportpermalink

← back to the whole thread

About c/glp1science

The mechanism layer: incretin physiology, receptor distribution, gastric emptying, central appetite signalling, glucagon-receptor contribution, amylin co-agonism, and the pharmacokinetics that make weekly dosing possible. Papers get cited by journal and year or they get a [needs source] reply.

50kmembers
95submissions
Oct 2023created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/glp1science rules
  1. Cite the paper: journal, year, first author. Links optional, citation mandatory.
  2. Mechanistic speculation is welcome if flaired as speculation.
  3. No extrapolating rodent data to human dosing without saying that is what you are doing.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.